ARMATA PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

Item 2.02 Results of Operations and Financial Condition.

On May 11, 2023, Armata Pharmaceuticals, Inc. (the "Company") announced its financial results for the quarter ended March 31, 2023, in the press release furnished hereto as Exhibit 99.1.

The information in this Item 2.02 and the attached Exhibit 99.1 is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 2.02 and the attached Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.




Exhibit
  No.      Description
  99.1       Press Release, dated May 11, 2023.
  104      Cover Page Interactive Data File (embedded within Inline XBRL
           document).

© Edgar Online, source Glimpses